Could Metformin Reduce Cancer Death Risk?

  • Apr 2016

Metformin, one of the most widely prescribed diabetes drugs, may have a new, hidden benefit: reducing the risk of dying from some cancers in postmenopausal women with type 2 diabetes, HealthDay reports.

These findings are from a new study in International Journal of Cancer, which found that for women with type 2 diabetes and cancer who are taking Metformin, the risk of dying from cancer was the same as diabetes-free women with cancer. In women with cancer and diabetes who weren’t taking Metformin, their risk of dying from cancer appeared to be  45% higher.

Read complete story.

You may also like

  • Liraglutide Increases Insulin Sensitivity Independent of Weight Loss, Study Shows

    Liraglutide, the glucagon-like peptide-1 receptor (GLP-1R) agonist used to treat type 2 diabetes and obesity, can lead to rapid improvement in insulin sensitivity, according to a study recently published in Diabetes. “We know that GLP-1R agonists promote weight loss, but we were surprised to find that the GLP-1R agonist liraglutide also has rapid effects on…

  • COVID-19 Vaccines and Hyperglycemia in Patients with Type 1 Diabetes

    By Derek Bagley

    While proven to be safe, the COVID-19 vaccines could cause some people with type 1 diabetes to see their blood sugar to temporarily spike. The key for both patient and provider is to remain vigilant with glucose testing and insulin dosing post-jab to maintain glycemic control.  In the summer of 2021, a 24-year-old woman presented…

Find more in